PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy

NCT02005432 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy

Interventions

DRUG: Intravitreal Ranibizumabe
DRUG: panfotocoagulation (PASCAL)
DRUG: panfotocoagulation (PRP) single shoot (ETDRS)

Sponsor

University of Sao Paulo